Colon cancer is one of the fastest-growing cancers worldwide. Despite meaningful advances in screening and detection, the number of cases continues to rise each year. For many patients, treatment remains physically and emotionally demanding. Surgery often involves removing the malignancy, resecting part of the colon, and temporarily diverting the intestine to a colostomy bag. Even...Read More

The term “life sciences” typically covers biotechnology, pharmaceuticals, medical devices, diagnostics, and increasingly the intersection of health care + technology (digital health, MedTech, genomics). Essentially: anything that uses biological science in service of human health. From an investor’s perspective, life sciences is interesting because: It speaks to large, long-term secular trends: aging populations, increasing chronic...Read More

The biotech sector in 2026 is offering one of the most dynamic investment landscapes we’ve seen in years. With scientific breakthroughs, regulatory changes, and technological convergence all aligning, this is a moment where strategic investors can capture outsized value. Below are the key forces to understand—and how they translate into actionable opportunities. 1. The Technology...Read More

AI isn’t just improving—it’s accelerating. A few key measures: According to the Stanford Institute for Human‑Centered Artificial Intelligence’s AI Index 2025, key benchmarks like MMLU (multitask language understanding) and GPQA (general purpose question answering) have improved dramatically in the last year. For example,  inference cost at the level of GPT-3.5 dropped from around $20 per...Read More